Literature DB >> 10922078

Presenilin complexes with the C-terminal fragments of amyloid precursor protein at the sites of amyloid beta-protein generation.

W Xia1, W J Ray, B L Ostaszewski, T Rahmati, W T Kimberly, M S Wolfe, J Zhang, A M Goate, D J Selkoe.   

Abstract

An unusual intramembranous cleavage of the beta-amyloid precursor protein (APP) by gamma-secretase is the final step in the generation of amyloid beta-peptide (Abeta). Two conserved aspartates in transmembrane (TM) domains 6 and 7 of presenilin (PS) 1 are required for Abeta production by gamma-secretase. Here we report that the APP C-terminal fragments, C83 and C99, which are the direct substrates of gamma-secretase, can be coimmunoprecipitated with both PS1 and PS2. PS/C83 complexes were detected in cells expressing endogenous levels of PS. The complexes accumulate when gamma-secretase is inactivated either pharmacologically or by mutating the PS aspartates. PS1/C83 and PS1/C99 complexes were detected in Golgi-rich and trans-Golgi network-rich vesicle fractions. In contrast, complexes of PS1 with APP holoprotein, which is not the immediate substrate of gamma-secretase, occurred earlier in endoplasmic reticulum-rich vesicles. The major portion of intracellular Abeta at steady state was found in the same Golgi/trans-Golgi network-rich vesicles, and Abeta levels in these fractions were markedly reduced when either PS1 TM aspartate was mutated to alanine. Furthermore, de novo generation of Abeta in a cell-free microsomal reaction occurred specifically in these same vesicle fractions and was markedly inhibited by mutating either TM aspartate. Thus, PSs are complexed with the gamma-secretase substrates C83 and C99 in the subcellular locations where Abeta is generated, indicating that PSs are directly involved in the pathogenically critical intramembranous proteolysis of APP.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10922078      PMCID: PMC16862          DOI: 10.1073/pnas.97.16.9299

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Interaction between amyloid precursor protein and presenilins in mammalian cells: implications for the pathogenesis of Alzheimer disease.

Authors:  W Xia; J Zhang; R Perez; E H Koo; D J Selkoe
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  Formation of stable complexes between two Alzheimer's disease gene products: presenilin-2 and beta-amyloid precursor protein.

Authors:  A Weidemann; K Paliga; U Dürrwang; C Czech; G Evin; C L Masters; K Beyreuther
Journal:  Nat Med       Date:  1997-03       Impact factor: 53.440

3.  Enhanced production and oligomerization of the 42-residue amyloid beta-protein by Chinese hamster ovary cells stably expressing mutant presenilins.

Authors:  W Xia; J Zhang; D Kholodenko; M Citron; M B Podlisny; D B Teplow; C Haass; P Seubert; E H Koo; D J Selkoe
Journal:  J Biol Chem       Date:  1997-03-21       Impact factor: 5.157

4.  Light and electron microscopic localization of presenilin-1 in primate brain.

Authors:  J J Lah; C J Heilman; N R Nash; H D Rees; H Yi; S E Counts; A I Levey
Journal:  J Neurosci       Date:  1997-03-15       Impact factor: 6.167

5.  Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissue.

Authors:  M B Podlisny; M Citron; P Amarante; R Sherrington; W Xia; J Zhang; T Diehl; G Levesque; P Fraser; C Haass; E H Koo; P Seubert; P St George-Hyslop; D B Teplow; D J Selkoe
Journal:  Neurobiol Dis       Date:  1997       Impact factor: 5.996

6.  Intracellular generation and accumulation of amyloid beta-peptide terminating at amino acid 42.

Authors:  C Wild-Bode; T Yamazaki; A Capell; U Leimer; H Steiner; Y Ihara; C Haass
Journal:  J Biol Chem       Date:  1997-06-27       Impact factor: 5.157

7.  Neurogenic phenotypes and altered Notch processing in Drosophila Presenilin mutants.

Authors:  Y Ye; N Lukinova; M E Fortini
Journal:  Nature       Date:  1999-04-08       Impact factor: 49.962

8.  Alzheimer's A beta(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells.

Authors:  D G Cook; M S Forman; J C Sung; S Leight; D L Kolson; T Iwatsubo; V M Lee; R W Doms
Journal:  Nat Med       Date:  1997-09       Impact factor: 53.440

9.  Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides.

Authors:  T Hartmann; S C Bieger; B Brühl; P J Tienari; N Ida; D Allsop; G W Roberts; C L Masters; C G Dotti; K Unsicker; K Beyreuther
Journal:  Nat Med       Date:  1997-09       Impact factor: 53.440

10.  A substrate-based difluoro ketone selectively inhibits Alzheimer's gamma-secretase activity.

Authors:  M S Wolfe; M Citron; T S Diehl; W Xia; I O Donkor; D J Selkoe
Journal:  J Med Chem       Date:  1998-01-01       Impact factor: 7.446

View more
  35 in total

1.  Inhibition of intracellular cholesterol transport alters presenilin localization and amyloid precursor protein processing in neuronal cells.

Authors:  Heiko Runz; Jens Rietdorf; Inge Tomic; Marina de Bernard; Konrad Beyreuther; Rainer Pepperkok; Tobias Hartmann
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

2.  Activity-dependent isolation of the presenilin- gamma -secretase complex reveals nicastrin and a gamma substrate.

Authors:  William P Esler; W Taylor Kimberly; Beth L Ostaszewski; Wenjuan Ye; Thekla S Diehl; Dennis J Selkoe; Michael S Wolfe
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

Review 3.  Presenilin, Notch, and the genesis and treatment of Alzheimer's disease.

Authors:  D J Selkoe
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

4.  In vivo reconstitution of gamma-secretase in Drosophila results in substrate specificity.

Authors:  Denise Stempfle; Ritu Kanwar; Alexander Loewer; Mark E Fortini; Gunter Merdes
Journal:  Mol Cell Biol       Date:  2010-04-26       Impact factor: 4.272

5.  Sorting of the Alzheimer's disease amyloid precursor protein mediated by the AP-4 complex.

Authors:  Patricia V Burgos; Gonzalo A Mardones; Adriana L Rojas; Luis L P daSilva; Yogikala Prabhu; James H Hurley; Juan S Bonifacino
Journal:  Dev Cell       Date:  2010-03-16       Impact factor: 12.270

6.  Imaging the Intracellular Trafficking of APP with Photoactivatable GFP.

Authors:  Joshua H K Tam; Stephen H Pasternak
Journal:  J Vis Exp       Date:  2015-10-17       Impact factor: 1.355

Review 7.  The study of Golgi apparatus in Alzheimer's disease.

Authors:  Zhiping Hu; Liuwang Zeng; Zhiling Huang; Jie Zhang; Ting Li
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 3.996

Review 8.  Potential treatment opportunities for Alzheimer's disease through inhibition of secretases and Abeta immunization.

Authors:  D Schenk; D Games; P Seubert
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

9.  Clinical and neuropathological features of the arctic APP gene mutation causing early-onset Alzheimer disease.

Authors:  Hans Basun; Nenad Bogdanovic; Martin Ingelsson; Ove Almkvist; Jan Näslund; Karin Axelman; Thomas D Bird; David Nochlin; Gerard D Schellenberg; Lars-Olof Wahlund; Lars Lannfelt
Journal:  Arch Neurol       Date:  2008-04

10.  Aging-related correlation of insulin-degrading enzyme with gamma-secretase-generated products involving insulin and glucose levels in transgenic mice.

Authors:  Dae Y Hwang; Jung S Cho; Chuel K Kim; Sun B Shim; Seung W Jee; Su H Lee; Su J Seo; Joon Y Cho; Seok H Lee; Yong K Kim
Journal:  Neurochem Res       Date:  2005-09       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.